Lexicon Pharmaceuticals
LXRX
#6532
Rank
ยฃ0.52 B
Marketcap
ยฃ1.24
Share price
1.23%
Change (1 day)
182.43%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ87.43 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company has ยฃ87.43 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lexicon Pharmaceuticals - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.18 B42.08%
2023-12-31ยฃ0.13 B16.7%
2022-12-31ยฃ0.11 B77.97%
2021-12-31ยฃ64.26 M-42.48%
2020-12-31ยฃ0.11 B-46.07%
2019-12-31ยฃ0.20 B64.3%
2018-12-31ยฃ0.12 B-45.17%
2017-12-31ยฃ0.22 B-18.11%
2016-12-31ยฃ0.28 B-20.18%
2015-12-31ยฃ0.35 B61.41%
2014-12-31ยฃ0.21 B178.42%
2013-12-31ยฃ78.28 M-43.31%
2012-12-31ยฃ0.13 B-23.8%
2011-12-31ยฃ0.18 B32.52%
2010-12-31ยฃ0.13 B36.17%
2009-12-31ยฃ0.10 B42.75%
2008-12-31ยฃ70.35 M-45.99%
2007-12-31ยฃ0.13 B218.94%
2006-12-31ยฃ40.84 M-29.35%
2005-12-31ยฃ57.81 M26.76%
2004-12-31ยฃ45.6 M-21.58%
2003-12-31ยฃ58.16 M-0.38%
2002-12-31ยฃ58.38 M-43.47%
2001-12-31ยฃ0.10 B-23.94%
2000-12-31ยฃ0.13 B2296.25%
1999-12-31ยฃ5.66 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ7.61 B 8,614.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ1.23 B 1,308.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ6.48 B 7,321.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
ยฃ0.51 B 486.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.57 B 552.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ69.71 M-20.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
ยฃ0.13 B 48.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.17 B 1,245.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
ยฃ2.29 M-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA